Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Liabilities and Shareholders Equity (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Liabilities and Shareholders Equity data on record, last reported at $246.6 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 21.68% to $246.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 30.06% increase, with the full-year FY2025 number at $261.0 million, up 70.72% from a year prior.
  • Liabilities and Shareholders Equity reached $246.6 million in Q1 2026 per TECX's latest filing, down from $261.0 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for TECX hit a ceiling of $314.8 million in Q1 2025 and a floor of $39.4 million in Q4 2023.
  • A 5-year average of $172.0 million and a median of $152.9 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: plummeted 62.1% in 2023, then surged 288.09% in 2024.
  • Tracing TECX's Liabilities and Shareholders Equity over 5 years: stood at $103.9 million in 2022, then tumbled by 62.1% to $39.4 million in 2023, then soared by 288.09% to $152.9 million in 2024, then soared by 70.72% to $261.0 million in 2025, then decreased by 5.54% to $246.6 million in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for TECX at $246.6 million in Q1 2026, $261.0 million in Q4 2025, and $277.0 million in Q3 2025.